Krystal Biotech Inc (KRYS)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 65,694 27,453 -20,973 -67,587 -109,726 -147,635 -153,093 -143,798 -145,197 -132,302 -116,503 -104,143 -68,274 -56,818 -50,846 -41,407 -33,000 -28,734 -24,396 -23,332
Revenue (ttm) US$ in thousands 293,354 247,796 172,511 103,808 58,154 10,946 2,390 809 0 0 0 0 0 0 0 0 0 0 0 542
Operating profit margin 22.39% 11.08% -12.16% -65.11% -188.68% -1,348.76% -6,405.56% -17,774.78% -4,304.80%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $65,694K ÷ $293,354K
= 22.39%

The operating profit margin of Krystal Biotech Inc has been fluctuating significantly over the periods reviewed. The margin was notably negative for most of the years, with a substantial decrease of -17,774.78% in March 2023 followed by a decrease of -6,405.56% in June 2023. However, there has been a gradual improvement since then, with the margin moving into negative but less extreme values. Notably, by December 2024, the operating profit margin showed a positive value of 22.39%, indicating a significant recovery in profitability. This suggests that the company has made some operational adjustments and improvements that have positively impacted its ability to generate profits from its core business activities.